ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Ariad Pharmaceuticals

Include trials that are no longer recruiting patients.

5 studies were found.
1.RecruitingSafety Study of AP23573 in Patients with Advanced, Refractory or Recurrent Malignancies
Conditions: Tumors; Lymphoma; Multiple Myeloma
2.No longer recruitingSafety Study of AP23573 in Patients with Advanced, Refractory or Recurrent Malignancies
Conditions: Tumors; Lymphoma; Multiple Myeloma
3.RecruitingSafety Study of AP23573 in Patients with Progressive or Recurrent Glioma
Conditions: Malignant Glioma; Glioblastoma; Gliosarcoma
4.RecruitingStudy of AP23573 in Patients with Relapsed or Refractory Hematologic Malignancies
Conditions: Hematologic Malignancies; Leukemia; Myelodysplastic Syndromes; Myeloid Metaplasia; Lymphoma
5.RecruitingStudy of AP23573, an mTOR Inhibitor, in Patients with Advanced Sarcoma
Conditions: Leiomyosarcoma; Liposarcoma; Osteosarcoma; Sarcoma, Soft Tissue; Metastases

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act